875,333 Shares in Cigna Group $CI Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company bought a new stake in Cigna Group (NYSE:CIFree Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 875,333 shares of the health services provider’s stock, valued at approximately $241,312,000. The Manufacturers Life Insurance Company owned approximately 0.33% of Cigna Group as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Evercore Wealth Management LLC lifted its stake in shares of Cigna Group by 2.8% in the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after acquiring an additional 35 shares during the period. Cary Street Partners Investment Advisory LLC increased its stake in shares of Cigna Group by 11.0% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares during the period. IHT Wealth Management LLC raised its holdings in Cigna Group by 2.5% during the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after purchasing an additional 38 shares in the last quarter. Whetstone Capital Advisors LLC raised its holdings in Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after purchasing an additional 39 shares in the last quarter. Finally, CYBER HORNET ETFs LLC lifted its position in Cigna Group by 5.3% in the fourth quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Up 1.0%

Shares of CI opened at $280.32 on Tuesday. The business’s 50-day moving average price is $283.92 and its 200 day moving average price is $281.48. The stock has a market capitalization of $74.07 billion, a P/E ratio of 11.60, a P/E/G ratio of 0.95 and a beta of 0.29. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the company earned $7.20 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is currently 25.82%.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CI shares. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research note on Tuesday, June 16th. UBS Group upped their price objective on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Sanford C. Bernstein raised their target price on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Check Out Our Latest Stock Report on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.